Apyx Medical Corporation

9.88+0.2400+2.49%Vol 120.77K1Y Perf 178.93%
Apr 20th, 2021 16:00 DELAYED
BID8.44 ASK10.08
Open9.55 Previous Close9.64
Pre-Market- After-Market-
 - -  - -%
Target Price
10.33 
Analyst Rating
Moderate Buy 2.00
Potential %
4.55 
Finscreener Ranking
★★★★     54.18
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
★★★★     56.13
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
★★     45.09
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Market Cap339.06M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
76.85 
Earnings Date
12th May 2021

Today's Price Range

9.459.98

52W Range

2.8112.01

5 Year PE Ratio Range

-13.4015.10

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
4.66%
1 Month
-7.06%
3 Months
-6.35%
6 Months
68.60%
1 Year
178.93%
3 Years
171.43%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
APYX9.880.24002.49
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Financial StrengthValueIndustryS&P 500US Markets
6.50
7.20
0.00
0.01
-420.90
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
63.20
-69.90
-66.70
-38.10
-43.94
RevenueValueIndustryS&P 500US Markets
22.71M
0.66
-11.47
-4.40
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.13-0.0469.23
Q03 2020-0.16-0.1318.75
Q02 2020-0.17-0.1417.65
Q01 2020-0.22-0.0672.73
Q04 2019-0.19-0.1615.79
Q03 2019-0.18-0.1327.78
Q02 2019-0.18-0.1327.78
Q01 2019-0.18-0.1422.22
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.150.00-
6/2021 QR-0.140.00-
12/2021 FY-0.56-9.80Negative
12/2022 FY-0.442.22Positive
Next Report Date12th May 2021
Estimated EPS Next Report-0.15
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume120.77K
Shares Outstanding34.32M
Trades Count973
Dollar Volume1.02M
Avg. Volume97.77K
Avg. Weekly Volume111.09K
Avg. Monthly Volume101.63K
Avg. Quarterly Volume91.18K

Apyx Medical Corporation (NASDAQ: APYX) stock closed at 9.88 per share at the end of the most recent trading day (a 2.49% change compared to the prior day closing price) with a volume of 120.77K shares and market capitalization of 339.06M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 266 people. Apyx Medical Corporation CEO is Charles D. Goodwin.

The one-year performance of Apyx Medical Corporation stock is 178.93%, while year-to-date (YTD) performance is 37.22%. APYX stock has a five-year performance of %. Its 52-week range is between 2.81 and 12.01, which gives APYX stock a 52-week price range ratio of 76.85%

Apyx Medical Corporation currently has a PE ratio of -26.80, a price-to-book (PB) ratio of 5.19, a price-to-sale (PS) ratio of 14.56, a price to cashflow ratio of 133.80, a PEG ratio of 2.32, a ROA of -14.30%, a ROC of -22.49% and a ROE of -16.84%. The company’s profit margin is -43.94%, its EBITDA margin is -66.70%, and its revenue ttm is $22.71 Million , which makes it $0.66 revenue per share.

Of the last four earnings reports from Apyx Medical Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. Apyx Medical Corporation’s next earnings report date is 12th May 2021.

The consensus rating of Wall Street analysts for Apyx Medical Corporation is Moderate Buy (2), with a target price of $10.33, which is +4.55% compared to the current price. The earnings rating for Apyx Medical Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Apyx Medical Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Apyx Medical Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.80, ATR14 : 0.63, CCI20 : 6.34, Chaikin Money Flow : 0.03, MACD : -0.05, Money Flow Index : 46.51, ROC : -0.21, RSI : 59.94, STOCH (14,3) : 62.18, STOCH RSI : 0.43, UO : 53.36, Williams %R : -37.82), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Apyx Medical Corporation in the last 12-months were: Charles D. Goodwin (Buy at a value of $93 197), Lawrence J. Waldman (Option Excercise at a value of $15 632), Michael Geraghty (Option Excercise at a value of $21 075)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
1 (50.00 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (50.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Strong Buy
1.50

Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. The company's product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives majority revenue.

CEO: Charles D. Goodwin

Telephone: +1 727 384-2323

Address: 5115 Ulmerton Road, Clearwater 33760, FL, US

Number of employees: 266

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

60%40%

Bearish Bullish

53%47%

Bearish Bullish

63%37%

Bearish Bullish

52%48%

News

Stocktwits